ABSTRACT
OBJECTIVE: With the current SARS-CoV2 outbreak, countless tests need to be performed on potential symptomatic individuals, contacts and travellers. The gold standard is a quantitative polymerase chain reaction (qPCR)-based system taking several hours to confirm positivity. For effective public health containment measures, this time span is too long. We therefore evaluated a rapid test in a high-prevalence community setting. STUDY DESIGN: Thirty-nine randomly selected individuals at a COVID-19 screening centre were simultaneously tested via qPCR and a rapid test. Ten previously diagnosed individuals with known SARS-CoV-2 infection were also analysed. METHODS: The evaluated rapid test is an IgG/IgM-based test for SARS-CoV-2 with a time to result of 20 min. Two drops of blood are needed for the test performance. RESULTS: Of 49 individuals, 22 tested positive by repeated qPCR. In contrast, the rapid test detected only eight of those positive correctly (sensitivity: 36.4%). Of the 27 qPCR-negative individuals, 24 were detected correctly (specificity: 88.9%). CONCLUSION: Given the low sensitivity, we recommend not to rely on an antibody-based rapid test for public health measures such as community screenings.
Subject(s)
Betacoronavirus/isolation & purification , Clinical Laboratory Techniques/standards , Community Health Services , Coronavirus Infections/diagnosis , Disease Outbreaks , Mass Screening/standards , Pneumonia, Viral/diagnosis , Point-of-Care Testing , Adult , Aged , COVID-19 , COVID-19 Testing , Coronavirus Infections/epidemiology , Female , Humans , Male , Mass Screening/methods , Middle Aged , Pandemics , Pneumonia, Viral/epidemiology , Polymerase Chain Reaction , SARS-CoV-2 , Sensitivity and Specificity , Time FactorsABSTRACT
Many non-equilibrium phenomena have been discovered or predicted in optically-driven quantum solids1. Examples include light-induced superconductivity2,3 and Floquet-engineered topological phases4-8. These are short lived effects that should lead to measurable changes in electrical transport, which can be characterized using an ultrafast device architecture based on photoconductive switches9. Here, we report the observation of a light-induced anomalous Hall effect in monolayer graphene driven by a femtosecond pulse of circularly polarized light. The dependence of the effect on a gate potential used to tune the Fermi level reveals multiple features that reflect a Floquet-engineered topological band structure4,5, similar to the band structure originally proposed by Haldane10. This includes an approximately 60 meV wide conductance plateau centered at the Dirac point, where a gap of equal magnitude is predicted to open. We find that when the Fermi level lies within this plateau, the estimated anomalous Hall conductance saturates around 1.8±0.4 e2/h.
ABSTRACT
BACKGROUND: MRSA is a therapeutic concern worldwide, and a major agent of community-acquired skin and soft tissue infections (CA-SSTIs). While the US epidemiology of MRSA in CA-SSTIs is well described and reports the high prevalence of the USA300 clone, data on the European situation are lacking. OBJECTIVES: To determine the prevalence and clonal characteristics of MRSA in CA-SSTIs in seven European emergency departments. PATIENTS AND METHODS: From April to June 2015, patients presenting to the tertiary hospital emergency department with a Staphylococcus aureus CA-SSTI were prospectively enrolled. S. aureus isolates were characterized by antimicrobial susceptibility testing, detection of Panton-Valentine leucocidin encoding genes and spa-typing, MLST and/or DNA microarray. RESULTS: Two-hundred and five cases of S. aureus-associated CA-SSTIs were included, comprising folliculitis, furuncles, abscesses, paronychia, impetigo, carbuncles and cellulitis. Of the 205 cases, we report an MRSA prevalence rate of 15.1%, with a north (0%) to south (29%) increasing gradient. Fifty-one isolates were Panton-Valentine leucocidin-positive (24.9%), whether MSSA or MRSA, with a heterogeneous distribution between countries. Clonal distribution of MSSA and MRSA showed high diversity, with no predominant circulating clone and no archetypical USA300 CA-MRSA clone. CONCLUSIONS: This original prospective multicentre study highlights stark differences in European MRSA epidemiology compared with the USA, and that the USA300 CA-MRSA clone is not predominant among community-infected patients in Europe.
Subject(s)
Community-Acquired Infections/epidemiology , Emergency Service, Hospital , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Soft Tissue Infections/epidemiology , Staphylococcal Infections/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Bacterial Toxins/genetics , Child , Child, Preschool , Community-Acquired Infections/microbiology , Europe/epidemiology , Exotoxins/genetics , Female , Genotype , Humans , Infant , Leukocidins/genetics , Male , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/genetics , Microarray Analysis , Microbial Sensitivity Tests , Middle Aged , Molecular Epidemiology , Multilocus Sequence Typing , Oligonucleotide Array Sequence Analysis , Prevalence , Prospective Studies , Soft Tissue Infections/microbiology , Staphylococcal Infections/microbiology , Staphylococcal Protein A/genetics , Tertiary Care Centers , Young AdultABSTRACT
Derailment of immune responses can lead to autoimmune type 1 diabetes, and this can be accelerated or even induced by local stress caused by inflammation or infection. Dendritic cells (DCs) shape both innate and adaptive immune responses. Here, we report on the responses of naturally occurring human myeloid BDCA1(+) DCs towards differentially stressed pancreatic ß cells. Our data show that BDCA1(+) DCs in human pancreas-draining lymph node (pdLN) suspensions and blood-derived BDCA1(+) DCs both effectively engulf ß cells, thus mimicking physiological conditions. Upon uptake of enterovirus-infected, but not mock-infected cells, BDCA1(+) DCs induced interferon (IFN)-α/ß responses, co-stimulatory molecules and proinflammatory cytokines and chemokines. Notably, induction of stress in ß cells by ultraviolet irradiation, culture in serum-free medium or cytokine-induced stress did not provoke strong DC activation, despite efficient phagocytosis. DC activation correlated with the amount of virus used to infect ß cells and required RNA within virally infected cells. DCs encountering enterovirus-infected ß cells, but not those incubated with mock-infected or stressed ß cells, suppressed T helper type 2 (Th2) cytokines and variably induced IFN-γ in allogeneic mixed lymphocyte reaction (MLR). Thus, stressed ß cells have little effect on human BDCA1(+) DC activation and function, while enterovirus-infected ß cells impact these cells significantly, which could help to explain their role in development of autoimmune diabetes in individuals at risk.
Subject(s)
Antigens, CD1/immunology , Cell Communication/immunology , Dendritic Cells/immunology , Enterovirus B, Human/immunology , Glycoproteins/immunology , Insulin-Secreting Cells/immunology , Animals , Antigens, CD1/genetics , Coculture Techniques , Culture Media, Serum-Free/pharmacology , Dendritic Cells/cytology , Dendritic Cells/drug effects , Enterovirus B, Human/pathogenicity , Gene Expression , Glycoproteins/genetics , Host-Pathogen Interactions , Humans , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/pathology , Insulin-Secreting Cells/virology , Interferon-gamma/pharmacology , Interleukin-1beta/pharmacology , Mice , Phagocytosis/drug effects , Poly I-C/pharmacology , Primary Cell Culture , Signal Transduction , Stress, Physiological , Tumor Necrosis Factor-alpha/pharmacology , Ultraviolet RaysABSTRACT
The compartmentalization of microgels is a challenging task for synthetic polymer chemistry. Although the complexation with low molecular weight compounds or the use of microfluidic techniques offer attractive possibilities for other length scales, it is difficult to implement compartments in the mesoscale range of 10-100 nm. Herein we show how simple blending of reactive prepolymers is suitable to design new microgel morphologies with tailored compartments. We use poly(EEGE)-block-poly(AGE) as crosslinkable, pro-hydrophilic prepolymer in blends with varying amounts of crosslinkable, yet hydrophobic poly(THF-stat-AllylEHO) or inert and hydrophobic polystyrene, and crosslink the allyl functional prepolymer(s) in a thiol-ene click-type reaction after miniemulsification. Our strategy shows how arrested versus free nanophase separation can be used to control easily the morphology and polarity of microgel particles.
ABSTRACT
BACKGROUND: Injecting drug users (IDUs) represent a major subpopulation of hepatitis C virus (HCV)-infected people in developed countries. Yet their uptake to treatment is generally low despite well-documented effectiveness of HCV treatment among former and active IDUs. The present study represents the first attempt to describe the HCV treatment coverage among IDUs and identify factors that affect treatment uptake in the Czech Republic. METHODS: From January to March 2011, a questionnaire survey was conducted among viral hepatitis treatment centres in the Czech Republic. RESULTS: From a total of 76 identified hepatitis treatment centres existing in the country, 39 provided HCV treatment to (mainly former or abstaining) IDUs in 2010. Most clinicians reported being cautious in initiating HCV treatment in IDUs. Abstinence, a screening phase before treatment initiation, opioid substitution treatment and an external evaluation by a specialist were often prerequisites for skrting treatment. However, HCV treatment centres rarely provided drug-use specific services. Financial constraints were also reported, further limiting the inclusion of IDUs into treatment, as non-users are widely preferred to active drug users. Clinicians reported no difference in treatment uptake and adherence between drug users and non-users, nor between opioid and methamphetamine users. CONCLUSION: A number of system- and provider-related factors limit HCV treatment in IDUs in the Czech Republic, despite permissive national clinical guidelines. Targeting these factors is crucial to reduce HCV prevalence at population level.
Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C/drug therapy , Hepatitis C/epidemiology , Patient Compliance , Substance Abuse, Intravenous/complications , Czech Republic/epidemiology , Drug Users/statistics & numerical data , Hepatitis C/etiology , Hepatitis C/psychology , Humans , Patients/psychology , Prevalence , Surveys and QuestionnairesABSTRACT
Metallo-ß-lactamases (MBLs) in Enterobacteriaceae are an increasing problem worldwide. This report describes the isolation of Citrobacter freundii carrying IMP-8 MBL from three patients during the period from March 2012 until March 2013 in Germany. The bla IMP-8 enzyme is predominantly found in Asia, where IMP-8 has spread to various enterobacterial species causing serious infections. To our best knowledge, this is the first report of bla IMP-8 habouring Enterobacteriaceae in Europe.
ABSTRACT
Numerous birth-control studies, epidemiological studies, and observational studies have investigated mental health and health care in childhood, adolescence and early adulthood, including prevalence, age at onset, adversities, illness persistence, service use, treatment delay and course of illness. Moreover, the impact of the burden of illness, of deficits of present health care systems, and the efficacy and effectiveness of early intervention services on mental health were evaluated. According to these data, most mental disorders start during childhood, adolescence and early adulthood. Many children, adolescents and young adults are exposed to single or multiple adversities, which increase the risk for (early) manifestations of mental diseases as well as for their chronicity. Early-onset mental disorders often persist into adulthood. Service use by children, adolescents and young adults is low, even lower than for adult patients. Moreover, there is often a long delay between onset of illness and first adequate treatment with a variety of linked consequences for a poorer psychosocial prognosis. This leads to a large burden of illness with respect to disability and costs. As a consequence several countries have implemented so-called "early intervention services" at the interface of child and adolescent and adult psychiatry. Emerging studies show that these health-care structures are effective and efficient. Part 1 of the present review summarises the current state of mental health in childhood, adolescence and early adulthood, including prevalence, age at onset, adversities, illness persistence, service use, and treatment delay with consequences.
Subject(s)
Health Services/statistics & numerical data , Mental Disorders/epidemiology , Mental Disorders/therapy , Mental Health , Adolescent , Age of Onset , Anxiety Disorders/epidemiology , Anxiety Disorders/therapy , Child , Female , Germany/epidemiology , Health Services/economics , Humans , Male , Mental Disorders/economics , Mood Disorders/epidemiology , Mood Disorders/therapy , Prevalence , Schizophrenia/epidemiology , Schizophrenia/therapy , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/therapy , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy , Young AdultABSTRACT
Numerous birth-control studies, epidemiological studies, and observational studies investigated mental health and health care in childhood, adolescence and early adulthood, including prevalence, age at onset, adversities, illness persistence, service use, treatment delay and course of illness. Moreover, the impact of the burden of illness, of deficits of present health care systems, and the efficacy and effectiveness of early intervention services on mental health were evaluated. According to these data, most mental disorders start during childhood, adolescence and early adulthood. Many children, adolescents and young adults are exposed to single or multiple adversities, which increase the risk for (early) manifestations of mental diseases as well as for their chronicity. Early-onset mental disorders often persist into adulthood. Service use of children, adolescents and young adults is low, even lower than in adult patients. Moreover, there is often a long delay between onset of illness and first adequate treatment with a variety of linked consequences for poorer psychosocial prognosis. This leads to a large burden of illness with respect to disability and costs. As a consequence several countries have implemented so-called "early intervention services" at the border of child and adolescent and adult psychiatry. Emerging studies show that these health care structures are effective and efficient. Part 2 of the present review focuses on illness burden including disability and costs, deficits of the present health care system in Germany, and efficacy and efficiency of early intervention services.
Subject(s)
Delivery of Health Care/statistics & numerical data , Delivery of Health Care/standards , Mental Health Services/statistics & numerical data , Mental Health Services/standards , Mental Health/statistics & numerical data , Adolescent , Child , Cost of Illness , Disability Evaluation , Early Intervention, Educational/statistics & numerical data , Female , Germany/epidemiology , Health Services Needs and Demand , Humans , Male , Psychiatry/economics , Treatment Outcome , Young AdultABSTRACT
BACKGROUND: The aryl hydrocarbon receptor (AhR) is a nuclear receptor and transcriptional regulator with pleiotropic effects. The production of potent AhR ligands by Malassezia yeasts, such as indirubin, indolo[3,2-b]carbazole (ICZ), tryptanthrin and malassezin, has been associated with the pathogenesis of seborrhoeic dermatitis and pityriasis versicolor. Antigen-presenting cells in the skin can encounter microbes in the presence of these bioactive metabolites that could potentially modulate their function. OBJECTIVES: To study the effects of the aforementioned naturally occurring ligands on AhR activation and Toll-like receptor (TLR)-induced maturation in human monocyte-derived dendritic cells (moDCs). METHODS: These indoles were screened for AhR activation capacity in moDCs employing CYP1A1 and CYP1B1 induction as read out and for their effects on the function of moDCs after TLR-ligand stimulation. RESULTS: Indirubin and ICZ were the most potent AhR ligands and were selected for subsequent experiments. Concurrent exposure of moDCs to indirubin or ICZ together with TLR agonists significantly augmented the AhR-mediated CYP1A1 and CYP1B1 gene expression. Additionally, mature DCs that were subsequently stimulated with AhR ligands showed increased AhR target gene expression. Moreover, these ligands limited TLR-induced phenotypic maturation (CD80, CD83, CD86, MHC II upregulation) of moDCs, reduced secretion of the inflammatory cytokines interleukin (IL)-6 and IL-12, and decreased their ability to induce alloreactive T-lymphocyte proliferation. CONCLUSIONS: These results demonstrate that AhR agonists of yeast origin are able to inhibit moDC responses to TLR ligands and that moDCs can adapt through increased transcription of metabolizing enzymes such as CYP1A1 and CYP1B1.
Subject(s)
Dendritic Cells/drug effects , Indoles/pharmacology , Malassezia , Receptors, Aryl Hydrocarbon/drug effects , Toll-Like Receptors/antagonists & inhibitors , Aryl Hydrocarbon Hydroxylases/metabolism , Carbazoles/pharmacology , Cells, Cultured , Cellular Senescence/physiology , Cytochrome P-450 CYP1A1/metabolism , Cytochrome P-450 CYP1B1 , Dendritic Cells/metabolism , Humans , Interleukin-12/biosynthesis , Interleukin-6/biosynthesis , Monocytes/drug effects , Monocytes/metabolism , Quinazolines/pharmacologySubject(s)
Bone Cements , Breast Neoplasms/surgery , Extravasation of Diagnostic and Therapeutic Materials/complications , Kyphoplasty/adverse effects , Lumbar Vertebrae/surgery , Osteolysis/surgery , Postoperative Complications/etiology , Pulmonary Embolism/etiology , Spinal Neoplasms/secondary , Spinal Neoplasms/surgery , Thoracic Vertebrae/surgery , Breast Neoplasms/diagnostic imaging , Epidural Space/blood supply , Extravasation of Diagnostic and Therapeutic Materials/diagnostic imaging , Female , Humans , Image Processing, Computer-Assisted , Lumbar Vertebrae/diagnostic imaging , Middle Aged , Osteolysis/diagnostic imaging , Phlebography , Postoperative Complications/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Spinal Neoplasms/diagnostic imaging , Thoracic Vertebrae/diagnostic imaging , Tomography, X-Ray ComputedABSTRACT
On the basis of international standards, health care in German prisons has been oriented along the principle of equivalence (equity of health care delivery for inmates compared with the health care delivery in the community). Against this background, selected health problems demonstrate not only isolated problems in adaptation and implementation of health care delivery, but also structural problems resulting from the parallel system of prison health care, which is separated from the general German health care insurance system. This review serves as a basis to present suggestions to rethink and reorganize prison-based health care services.
Subject(s)
Delivery of Health Care/organization & administration , Prisoners , Prisons/organization & administration , Public Health , GermanyABSTRACT
Injection drug use (IDU) and IDU-related infectious diseases such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections are highly prevalent among prisoners worldwide. However, little is known about the prevalence of IDUs, HCV/HIV and the availability of respective treatment options in German prisons. Data provided by prison physicians of 31 prisons, representing 14,537 inmates, were included in this analysis. The proportion of IDUs among all prisoners was 21.9%. Substitution treatment was available in three out of four prisons (74.2%). Overall, 1137 substitution treatments were provided annually with a wide range of treatment aims. The prevalence rate was 14.3% for HCV and 1.2% for HIV. Around 5.5% of all HCV-infected prisoners were in antiviral treatment annually, 86.5% of all HIV-positive inmates in antiretroviral HIV-treatment. Generally, substitution treatment, and HCV and HIV testing and treatment are available. However, due to abstinence-orientated treatment aims, substitution treatment is rarely available as maintenance treatment, and HCV/HIV-treatment is mainly provided for patients with an existing treatment before imprisonment. The inconsistent data quality necessitates changes in prison-related policy to improve surveillance and to generate aggregated data in German prisons. The selection process in this analysis might lead to overestimating the provision of substitution and antiviral HCV-treatment.
Subject(s)
Antiviral Agents/administration & dosage , HIV Infections/drug therapy , Hepatitis C/drug therapy , Opiate Substitution Treatment/statistics & numerical data , Prisons/statistics & numerical data , Substance Abuse, Intravenous/drug therapy , Antiviral Agents/therapeutic use , Cross-Sectional Studies , Germany/epidemiology , HIV Infections/epidemiology , Hepatitis C/epidemiology , Humans , Prevalence , Prisoners , Risk Factors , Substance Abuse, Intravenous/epidemiologyABSTRACT
In recent years, Clostridium difficile infection (CDI) has emerged as an increasing problem, both in in- and outpatients. In a rural region of southern Germany, the annual number of C. difficile toxin (Tcd)-positive patients has increased from 95 to 796 in the period from 2000 to 2007. Simultaneously, the proportion of positive tests among all Tcd examinations has risen from 7.0% to 12.8%, indicating that the higher number of affected patients was not solely due to an increase in the number of assays. Elevated numbers of CDI have recently been associated with outbreaks of the ribotype 027 strain, particularly in North America. This strain has also been isolated in Europe, including in Germany. Ribotyping and PCR testing for binary toxin genes of C. difficile strains isolated from in- and outpatients demonstrate a predominance (59%) of C. difficile ribotype 001, which exhibits antibiotic resistance to erythromycin, ciprofloxacin, and moxifloxacin, but lacks binary toxin genes. In summary, in our region of Germany, the number of patients affected by CDI has increased, probably due to spread of C. difficile ribotype 001.
Subject(s)
Clostridioides difficile/genetics , Clostridioides difficile/isolation & purification , Disease Outbreaks/statistics & numerical data , Enterocolitis, Pseudomembranous/epidemiology , Enterocolitis, Pseudomembranous/microbiology , Population Surveillance , Risk Assessment/methods , Clostridioides difficile/classification , Germany/epidemiology , Humans , Incidence , Polymerase Chain Reaction/statistics & numerical data , Prevalence , Ribotyping/statistics & numerical data , Risk FactorsABSTRACT
The high prevalence and incidence rates of the hepatitis C virus (HCV) infections in drug users demonstrate the urgent necessity for a coordinated national prevention strategy. In the shadow of HIV/AIDS the necessary attention to the rapid spreading of the hepatitis C in drug users was started late, without being able to reach the public attention level of HIV/AIDS. The present efforts in the primary and secondary prevention of the hepatitis C in drug users are obviously not sufficient to reduce the prevalence with long-lasting results. Substitution treatment is of central relevance in the prevention of hepatitis C in opiate-dependent subjects, but requires, as current data of the HCV incidence of substituted opiate dependents illustrate, a stronger HCV-specific accentuation. Further settings, which are relevant for the group of intravenous drug users, have to be accessed and sensitized. Furthermore structural and political efforts are necessary, in order to develop a systematic and evidence-based answer to the challenge of the HCV spreading in drug users, in particular due to the fact that a German HCV strategy is still lacking.
Subject(s)
Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Hepatitis C/epidemiology , Hepatitis C/prevention & control , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy , Comorbidity/trends , Germany , Hepatitis C/diagnosis , Humans , Substance-Related Disorders/diagnosisSubject(s)
Capsule Endoscopy , Graft vs Host Disease/diagnosis , Hematopoietic Stem Cell Transplantation/adverse effects , Intestinal Diseases/diagnosis , Intestine, Small/pathology , Disease Progression , Fatal Outcome , Female , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/methods , Humans , Intestinal Diseases/etiology , Leukemia, Myeloid/diagnosis , Leukemia, Myeloid/surgery , Middle Aged , Multiple Organ Failure/diagnosis , Risk Assessment , Severity of Illness Index , Transplantation, Homologous/adverse effectsABSTRACT
During 2004 and at the start of 2005 a university hospital in Southwest Germany was affected by an extensive outbreak of vancomycin-resistant Enterococcus faecium (VRE). Although the outbreak was contained, linezolid-resistant enterococci emerged during and after the outbreak as the usage of linezolid became more common. Linezolid resistance was no longer limited to VRE. Nosocomial spread of linezolid-resistant but vancomycin-susceptible E. faecium was detected and these strains also emerged in patients without prior drug exposure. Linezolid should therefore be used with caution and the susceptibility of isolates monitored over time. Isolation precautions and screening of contacts should be considered to avoid spread of resistant isolates.
Subject(s)
Acetamides/pharmacology , Enterococcus faecium/drug effects , Oxazolidinones/pharmacology , Protein Synthesis Inhibitors/pharmacology , Anti-Bacterial Agents/pharmacology , Disease Outbreaks , Drug Resistance, Bacterial , Enterococcus faecium/isolation & purification , Germany/epidemiology , Hospitals, University , Humans , Linezolid , Microbial Sensitivity Tests , Vancomycin ResistanceABSTRACT
Vancomycin-resistant enterococci (VRE) have been isolated in increasing numbers. Hospital-adapted VRE exhibit relatively high pathogenicity by expressing factors like enterococcal surface protein (Esp), which facilitates epidemic spread. By contrast, 'community-acquired' VRE show low pathogenicity and non-epidemic features. In 2004 and 2005 an extended outbreak of VRE occurred at a university hospital in Southwestern Germany and an infection control programme was implemented to confine the outbreak. Pulsed-field gel electrophoresis (PFGE), esp PCR, multiple-locus variable number of tandem repeat analysis (MLVA), purK1 typing and multiple-locus sequence typing (MLST) were performed on representative VRE isolates. Twenty-six non-epidemic and two epidemic VRE types (MLST203, MLST280) were identified by PFGE. Seven of the non-outbreak VRE types were esp gene negative, whereas 19 non-outbreak and both epidemic VRE types were esp positive. Eight MLVA types were identified. MLVA type 1 included five PFGE types and MLVA type 159 included 16 PFGE types. Currently there is no efficient method available to identify non-epidemic VRE and avoid unnecessary isolation of patients. More than 50% non-epidemic clones were esp positive; nevertheless, esp PCR appears to be the most promising approach to identify non-epidemic VRE.
Subject(s)
Bacterial Proteins/genetics , Cross Infection/microbiology , Disease Outbreaks/classification , Enterococcus faecium/classification , Gram-Positive Bacterial Infections/classification , Membrane Proteins/genetics , Vancomycin Resistance/genetics , Bacterial Proteins/classification , Bacterial Typing Techniques , Cross Infection/epidemiology , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecium/genetics , Enterococcus faecium/pathogenicity , Genotype , Germany/epidemiology , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/genetics , Hospitals, University , Humans , Membrane Proteins/classificationABSTRACT
PURPOSE: To determine the feasibility, efficacy and safety of balloon-assisted percutaneous vertebroplasty (BA-VP) in patients with osteoporotic vertebral compression fractures (VCFs). MATERIALS AND METHODS: In 47 patients (29 women, 18 men; mean age: 70 years and 4 months) with severe VCFs, 66 BA-VPs were performed via a unipedicular access. After initial puncture (under combined fluoroscopy and CT guidance) of the vertebral body (VB), the needle was retraced by 1.5 cm, and a 12-mm Fogarty balloon catheter was introduced and inflated using 2-4 ml diluted contrast media (CM). After the subsequent removal of the catheter and repositioning of the needle, vertebroplasty was performed. RESULTS: The mean volume of PMMA injected was 4.4 ml (2.5-7.2 ml). Pain reduction (measured by the Visual Analogue Scale) was achieved in 95 % of the patients, dropping from on average 8.0 pre-intervention to 2.2 after a mean follow-up of 8 months. A reduction of the pain relieving medication was achieved in 68 % of the cases and patient activity improved markedly. No severe or clinically relevant complications were observed. Cement leakage occurred by filling of epidural and paravertebral veins in 9.1 and 6.1 % of the cases, respectively. Leakage into the paravertebral soft tissues was seen in 3.0 % of the patients and to the adjacent disc space in 10.6 % of the cases. CONCLUSION: Vertebroplasty and kyphoplasty are currently used to treat osteoporotic VCFs but show either a comparatively high leakage rate or are rather complex and expensive. Balloon-assisted vertebroplasty seems to combine advantages from both methods and is effective, safe and comparatively inexpensive.
Subject(s)
Catheterization/methods , Fractures, Compression/surgery , Laminectomy/methods , Lumbar Vertebrae/surgery , Osteoporosis/complications , Osteoporosis/diagnostic imaging , Spinal Fractures/surgery , Aged , Back Pain/etiology , Back Pain/prevention & control , Cementation/methods , Female , Fracture Fixation, Internal/methods , Fractures, Compression/etiology , Humans , Lumbar Vertebrae/diagnostic imaging , Male , Osteoporosis/surgery , Pilot Projects , Radiography , Spinal Fractures/etiology , Treatment OutcomeABSTRACT
The incidence of vancomycin-resistant Enterococcus faecium isolation was low (Subject(s)
Bacterial Proteins/genetics
, Cross Infection/microbiology
, Drug Resistance, Multiple, Bacterial
, Enterococcus faecium/classification
, Gram-Positive Bacterial Infections/microbiology
, Hyaluronoglucosaminidase/genetics
, Membrane Proteins/genetics
, Acetamides/pharmacology
, Ampicillin Resistance
, Anti-Infective Agents/pharmacology
, Cross Infection/epidemiology
, DNA Restriction Enzymes
, Enterococcus faecium/drug effects
, Enterococcus faecium/genetics
, Enterococcus faecium/pathogenicity
, Germany/epidemiology
, Gram-Positive Bacterial Infections/epidemiology
, Humans
, Linezolid
, Oxazolidinones/pharmacology
, Phenotype
, Phylogeny
, Polymerase Chain Reaction/methods
, Vancomycin Resistance